Janney Montgomery Scott LLC Axsome Therapeutics, Inc. Transaction History
Janney Montgomery Scott LLC
- $35.8 Billion
- Q3 2024
A detailed history of Janney Montgomery Scott LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 7,199 shares of AXSM stock, worth $716,228. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,199
Previous 5,630
27.87%
Holding current value
$716,228
Previous $453,000
42.83%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding AXSM
# of Institutions
308Shares Held
40.3MCall Options Held
429KPut Options Held
615K-
Rtw Investments, LP New York, NY4.63MShares$461 Million6.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$397 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$328 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$235 Million37.71% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.85MShares$184 Million4.89% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.27B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...